drugset / Trial / NCT05915286
Diuretic Use in Hemodialysis Patients With Residual Renal Function
NaSingle-groupOpen-labelTreatment
Summary
This pilot trial will evaluate the use of diuretic medications (furosemide and chlorthalidone) in participants on dialysis to see if these medications work to preserve existing kidney function, increase urine output, and reduce weight gain between dialysis treatments. Diuretics, which are sometimes called water pills, help the body to get rid of salt (sodium) and water. There are currently no guidelines for the use of diuretic medications in dialysis patients, including the type to use, or how much to use.
Timeline
- Start
- 2023-05-29
- Primary completion
- 2025-02-21
- Completion
- 2025-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorthalidone | Other / unclassified | — | — |
| Subject | Furosemide | Other / unclassified | — | — |